Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pyxis Oncology Inc
(NQ:
PYXS
)
4.300
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
164,540
Open
4.270
Bid (Size)
4.300 (8)
Ask (Size)
4.560 (10)
Prev. Close
4.300
Today's Range
4.250 - 4.420
52wk Range
1.350 - 6.850
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 03, 2024
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly...
Via
Benzinga
Exposures
Glyphosate
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
April 03, 2024
U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Performance
YTD
+108.74%
+108.74%
1 Month
+0.94%
+0.94%
3 Month
+3.37%
+3.37%
6 Month
+173.89%
+173.89%
1 Year
+45.76%
+45.76%
More News
Read More
Pyxis Oncology: Q4 Earnings Insights
March 21, 2024
Via
Benzinga
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 28, 2024
From
Pyxis Oncology
Via
GlobeNewswire
3 Biotech Stocks to Buy on the Dip: March 2024
March 27, 2024
Via
InvestorPlace
Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights
March 27, 2024
From
Pyxis Oncology
Via
GlobeNewswire
Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
March 22, 2024
Via
Benzinga
Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 21, 2024
Via
Benzinga
PYXS Stock Earnings: Pyxis Oncology Beats EPS for Q4 2023
March 21, 2024
Via
InvestorPlace
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
March 21, 2024
From
Pyxis Oncology
Via
GlobeNewswire
From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires
March 19, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 15, 2024
Via
InvestorPlace
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
March 13, 2024
From
Pyxis Oncology
Via
GlobeNewswire
Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024
March 07, 2024
From
Pyxis Oncology
Via
GlobeNewswire
Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting
March 05, 2024
From
Pyxis Oncology
Via
GlobeNewswire
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 27, 2024
Via
Benzinga
Pyxis Oncology Announces $50 Million Private Placement
February 27, 2024
From
Pyxis Oncology
Via
GlobeNewswire
3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024
February 22, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
December 29, 2023
Via
Benzinga
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 29, 2023
From
Pyxis Oncology
Via
GlobeNewswire
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
November 28, 2023
From
Pyxis Oncology
Via
GlobeNewswire
Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update
November 07, 2023
From
Pyxis Oncology
Via
GlobeNewswire
New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year in Review
October 13, 2023
Via
FinancialNewsMedia
Exposures
Product Safety
NASDAQ:PYXS Investor Notice: Investigation over Possible Securities Laws Violations by Pyxis Oncology, Inc.
October 05, 2023
Via
SBWire
Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023
September 27, 2023
From
Pyxis Oncology
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.